SMAD2 and cancer: Previous studies have demonstrated that miR-552 functions as a potential oncogene in a series of cancer types and figure out several downstream targets, such as AJAP1 in liver cancer, Smad2 and DACH1 in colorectal cancer, TIMP2 and WIF1 in osteosarcoma 28-32.